Dutch Pharmacogenetics Working Group (DPWG) Guideline for the Gene-Drug Interaction of CYP2C9, HLA-A, and HLA-B with Anti-epileptic Drugs

Medicine, Basic Medical Sciences, Neurology, Pharmacy, Life Sciences, Genetics,
pharmacogenetics   anti-epileptic drugs   CYP2C9   HLA-A   HLA-B   drug interactions   personalized medicine  

Dutch Pharmacogenetics Working Group Guideline for CYP2C9, HLA-A and HLA-B Gene-Drug Interactions with Antiepileptic Drugs Background Pharmacogenetics (PGx) studies how genetic variations affect individual drug responses, aiming to guide drug selection and dosing, optimize drug therapy, prevent adverse drug reactions, and achieve safer and more cos...